Literature DB >> 9104977

The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer.

J Buhr1, K H Berghäuser, S Gonner, C Kelm, E A Burkhardt, W M Padberg.   

Abstract

METHODS: Three hundred forty-two patients with lung cancer and 99 patients with nonneoplastic lung diseases (control group) underwent intraoperative pleural lavage with 300 ml physiologic saline solution before (lavage I) and after resection (lavage II).
RESULTS: Studies of the lavage fluid in all control patients were negative, that is, there were no false positive findings. Tumor cells were found in lavage I in 132 patients (38.6%) and also in lavage II in 99 of them. In stage I (pT1 N0, pT2 N0) lung cancer, tumor cell detection was possible in 47 patients (28.6%). The 4-year survival of patients with resected non-small-cell lung cancer was 24% (95% confidence interval, 16% to 32%) if lavage I results were positive and 52% (95% confidence interval, 45% to 59%) if lavage I results were negative (all stages, p = 0.007). For patients with stage I disease (n = 164) the 4-year survival was 35% (95% confidence interval, 18% to 52%) if lavage I results were positive (n = 47), and 69% (95% confidence interval, 60% to 78%) if lavage I results were negative (n = 117) (p = 0.037). On multivariate analysis the positive cytologic result in intraoperative pleural lavage was an additional prognostic factor for our patients. To prove how the tumor cells enter the pleural cavity, we performed tissue cultures of tumor-free parenchyma in 23 cases of lung cancer. Tumor cell detection by histology and immunohistology was possible in 16 cases (69.6%). Detection of tumor cells in pleural lavage fluid before resection proves that tumor cells have spread into the pleural cavity.
CONCLUSION: The positive result in pleural lavage seems to be a prognostic predictor for patients with lung cancer.

Entities:  

Mesh:

Year:  1997        PMID: 9104977     DOI: 10.1016/S0022-5223(97)70225-3

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

1.  Role of surgery in multi-modality treatment for carcinomatous pleuritis in patients with non-small cell lung cancer.

Authors:  Tetsuhiko Go; Noriyuki Misaki; Natsumi Matsuura; Sung Soo Chang; Shintarou Tarumi; Hiroyasu Yokomise
Journal:  Surg Today       Date:  2014-07-19       Impact factor: 2.549

2.  Obligate progression precedes lung adenocarcinoma dissemination.

Authors:  Deborah R Caswell; Chen-Hua Chuang; Dian Yang; Shin-Heng Chiou; Shashank Cheemalavagu; Caroline Kim-Kiselak; Andrew Connolly; Monte M Winslow
Journal:  Cancer Discov       Date:  2014-04-16       Impact factor: 39.397

3.  Role of pleural lavage cytology before resection for primary lung carcinoma.

Authors:  M Okada; N Tsubota; M Yoshimura; Y Miyamoto; Y Maniwa
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

4.  Clinicopathological features of intraoperative pleural lavage cytology for non-small cell lung cancer.

Authors:  Ken Onodera; Akira Sakurada; Fumihiko Hoshi; Jiro Abe; Tohru Hasumi; Satomi Takahashi; Yasuki Saito; Yoshinori Okada
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-07-09

5.  The influence of intraoperative pleural perfusion with matrine-cisplatin or cisplatin on stromal cell-derived factor-1 in non-small cell lung cancer patients with subclinical pleural metastasis.

Authors:  Cheng-Liang Yang; Shun-Shou Liu; Ye-Gang Ma; Yong-Yu Liu; Yi-Xue Xue; Bo Huang
Journal:  Med Oncol       Date:  2011-02-11       Impact factor: 3.064

6.  Clinical value of pleural lavage cytological positivity in lung cancer patients without intraoperative malignant pleuritis. Recurrent pattern based on semiquantitative analysis of tumor cells in pleural lavage.

Authors:  M Higashiyama; K Kodama; H Yokouchi; K Takami; T Nakayama; T Horai
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-10

7.  Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer.

Authors:  B M Stiles; P S Adusumilli; A Bhargava; S F Stanziale; T H Kim; M-K Chan; R Huq; R Wong; V W Rusch; Y Fong
Journal:  Cancer Gene Ther       Date:  2006-01-01       Impact factor: 5.987

8.  Pleural lavage cytology predicts recurrence and survival, even in early non-small cell lung cancer.

Authors:  Federico Mazza; Enrico Ferrari; Paola Maineri; Beatrice Dozin; Giovanni Battista Ratto
Journal:  Surg Today       Date:  2014-05-10       Impact factor: 2.549

9.  Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH).

Authors:  M Fiegl; A Massoner; M Haun; W Sturm; H Kaufmann; R Hack; J Krugmann; M Fritzer-Szekeres; K Grünewald; G Gastl
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

10.  Cytological examination of pleural cavity lavage accompanied by the study of gene promoter hypermethylation of p16 and O6-methylguanine-DNA-methyltransferase genes in diagnostics of non-small cell lung cancer metastatic changes into pleura.

Authors:  Grzegorz Kaczmarczyk; Roman Lewandowski; Wanda Trautsolt; Adam Ziółkowski; Jerzy Kozielski
Journal:  Contemp Oncol (Pozn)       Date:  2012-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.